Unique evolution characteristics of the envelope protein of EIAV(LN₄₀), a virulent strain of equine infectious anemia virus (Q45368605)

13 December 2017

Unique evolution characteristics of the envelope protein of EIAV(LN₄₀), a virulent strain of equine infectious anemia virus (English)

1 reference

13 December 2017

0 references

equine infectious anemia

1 reference

equine infectious anemia virus

inferred from title

object named as

equine infectious anemia virus

1 reference

Xuefeng Wang

1

1 reference

13 December 2017

Shuai Wang

2

1 reference

13 December 2017

Yuezhi Lin

3

1 reference

13 December 2017

Chenggang Jiang

4

1 reference

13 December 2017

Jian Ma

5

1 reference

13 December 2017

Liping Zhao

6

1 reference

13 December 2017

Xiaoling Lv

7

1 reference

13 December 2017

Fenglong Wang

8

1 reference

13 December 2017

Rongxian Shen

9

1 reference

13 December 2017

Jianhua Zhou

10

1 reference

13 December 2017

8 January 2011

1 reference

13 December 2017

1 reference

13 December 2017

42

1 reference

13 December 2017

2

1 reference

13 December 2017

220-228

1 reference

https://scigraph.springernature.com/pub.10.1007/s11262-010-0563-7

13 December 2017

0 references

cites work

Equine infectious anemia virus genomic evolution in progressor and nonprogressor ponies.

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0563-7

An outbreak of equine infectious anaemia in Ireland during 2006: investigation methodology, initial source of infection, diagnosis and clinical presentation, modes of transmission and spread in the Meath cluster.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0563-7

[Equine Infectious Anemia (EIA)].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0563-7

Equine Infectious Anemia Virus (EIAV): what has HIV's country cousin got to tell us?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0563-7

Transient immune suppression of inapparent carriers infected with a principal neutralizing domain-deficient equine infectious anaemia virus induces neutralizing antibodies and lowers steady-state virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0563-7

Gag genetic heterogeneity of equine infectious anemia virus (EIAV) in naturally infected horses in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0563-7

Envelope variation as a primary determinant of lentiviral vaccine efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0563-7

Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0563-7

Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0563-7

Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0563-7

Characterization of the equine infectious anaemia virus S2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0563-7

Characterization of infectious molecular clones of equine infectious anaemia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0563-7

Immune selection of equine infectious anemia virus env variants during the long-term inapparent stage of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0563-7

Genetic and biological variation in equine infectious anemia virus Rev correlates with variable stages of clinical disease in an experimentally infected pony

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0563-7

Equine infectious anemia virus Gag p9 function in early steps of virus infection and provirus production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0563-7

Insertions, duplications and substitutions in restricted gp90 regions of equine infectious anaemia virus during febrile episodes in an experimentally infected horse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0563-7

Mutations occurring during serial passage of Japanese equine infectious anemia virus in primary horse macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0563-7

Replication ability in vitro and in vivo of equine infectious anemia virus avirulent Japanese strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0563-7

Genetic variation in the long terminal repeat associated with the transition of Chinese equine infectious anemia virus from virulence to avirulence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0563-7

Combined amino acid mutations occurring in the envelope closely correlate with pathogenicity of EIAV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0563-7

In vivo evolution of the gp90 gene and consistently low plasma viral load during transient immune suppression demonstrate the safety of an attenuated equine infectious anemia virus (EIAV) vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0563-7

Long terminal repeats are not the sole determinants of virulence for equine infectious anemia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0563-7

An EIAV field isolate reveals much higher levels of subtype variability than currently reported for the equine lentivirus family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0563-7

Genomic analysis of an effective lentiviral vaccine-attenuated equine infectious anemia virus vaccine EIAV FDDV13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0563-7

Identification of hypervariable and conserved regions in the surface envelope gene in the bovine lentivirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0563-7

Viral sequence diversity: challenges for AIDS vaccine designs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0563-7

Detection of minor populations of drug-resistant HIV-1 in acute seroconverters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0563-7

Apparent elimination of EIAV ancestral species in a long-term inapparent carrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0563-7

EIAV envelope diversity: shaping viral persistence and encumbering vaccine efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0563-7

Genotypic and phenotypic characterization of HIV-1 patients with primary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0563-7

Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0563-7

A conservative domain shared by HIV gp120 and EIAV gp90: implications for HIV vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0563-7

Virus glycosylation: role in virulence and immune interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0563-7

Amino acid mutations of the infectious clone from Chinese EIAV attenuated vaccine resulted in reversion of virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11262-010-0563-7

Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype

21 January 2018

1 reference

12 December 2020

Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection

1 reference

12 December 2020

Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony

1 reference

12 December 2020

[Study of the correlation between the plasma viral load and protective immunity induced by the equine infectious anemia attenuated vaccine and its parental virulent strain].

1 reference

12 December 2020

Viral DNA in horses infected with equine infectious anemia virus

1 reference

12 December 2020

Immunofluorescent localization of equine infectious anemia virus in tissue.

1 reference

12 December 2020

Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells

1 reference

12 December 2020

Wild-type equine infectious anemia virus replicates in vivo predominantly in tissue macrophages, not in peripheral blood monocytes

1 reference

12 December 2020

[Comparison of proviral genomes between the Chinese EIAV donkey leukocyte-attenuated vaccine and its parental virulent strain].

1 reference

12 December 2020

Evolution of a simian immunodeficiency virus pathogen.

1 reference

12 December 2020

Characterization of a cytolytic strain of equine infectious anemia virus

1 reference

12 December 2020

Equine infectious anemia virus trans-regulatory protein Rev controls viral mRNA stability, accumulation, and alternative splicing

1 reference

12 December 2020

Genomic quasispecies associated with the initiation of infection and disease in ponies experimentally infected with equine infectious anemia virus

1 reference

12 December 2020

Transmission of equine infectious anemia virus from horses without clinical signs of disease

1 reference

12 December 2020

[Construction and in vitro evaluation of an infectious clone of the equine infectious anemia virus vaccine strain EIAV(FDDV) with four reverse-mutated vaccine-specific sites in the S2 gene]

1 reference

12 December 2020

In vivo dynamics of equine infectious anemia viruses emerging during febrile episodes: insertions/duplications at the principal neutralizing domain

1 reference

12 December 2020

Detailed mapping of the antigenicity of the surface unit glycoprotein of equine infectious anemia virus by using synthetic peptide strategies

1 reference

12 December 2020

10.1007/S11262-010-0563-7

Identifiers

DOI

1 reference

Dimensions Publication ID

13 December 2017

0 references

1 reference